KVYO Rule 144 filing to sell 59,492 Series A shares on NYSE

Rhea-AI Filing Summary

KVYO filed a Form 144 notice for a proposed sale of 59,492 Series A shares, with an aggregate market value of $1,787,420.89. The shares were acquired on 09/25/2012 as founder shares, recorded as compensation. The filing lists Fidelity Brokerage Services LLC as broker and names the NYSE as the exchange, with an approximate sale date of 11/10/2025.

Recent activity disclosed includes sales during the past three months: Hodgkins LLC sold 67,524 Series A shares for $2,142,377.45 and Hodgkins Trust sold 22,224 Series A shares for $703,493.05 on 09/15/2025. This notice reflects an intent to sell under Rule 144 and does not itself complete a transaction.

Insights

Securities law analyst

Routine Rule 144 notice for planned insider share sales.

This filing signals an intended sale of restricted or control securities under Rule 144. The key figure is 59,492 Series A shares with an $1,787,420.89 aggregate market value, scheduled around 11/10/2025. The broker is Fidelity Brokerage Services LLC and the exchange listed is NYSE.

The document also lists recent sales within three months—67,524 and 22,224 shares with proceeds of $2,142,377.45 and $703,493.05. Actual sale execution and size may vary with market conditions and Rule 144 volume limits.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Series A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	59492	1787420.89	137856147	11/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series A	09/25/2012	Founder Shares	Issuer			59492	09/25/2012	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Hodgkins Llc 125 Summer Street, 6th Floor Boston MA 02110	Series A	09/15/2025	67524	2142377.45
Hodgkins Trust 125 Summer Street, 6th Floor Boston MA 02110	Series A	09/15/2025	22224	703493.05

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does KVYO’s Form 144 disclose?

It discloses an intent to sell 59,492 Series A shares with an aggregate market value of $1,787,420.89, listing the NYSE and Fidelity as broker.

When is the proposed sale date for KVYO’s shares?

The filing lists an approximate sale date of 11/10/2025.

How were the shares to be sold originally acquired?

They were acquired on 09/25/2012 as founder shares, recorded as compensation.

What recent sales are reported in the past three months?

Hodgkins LLC sold 67,524 shares for $2,142,377.45, and Hodgkins Trust sold 22,224 shares for $703,493.05 on 09/15/2025.

Which broker and exchange are listed for the proposed KVYO sale?

The broker is Fidelity Brokerage Services LLC and the exchange is the NYSE.